Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GISTs) are caused by gain-of-function mutations in the Kit receptor tyrosine kinase. Most primary GIST patients respond to the Kit inhibitor imatinib, but this drug often becomes ineffective because of secondary mutations in the Kit kinase domain. The characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Obata, Y, Horikawa, K, Takahashi, T, Akieda, Y, Tsujimoto, M, Fletcher, J A, Esumi, H, Nishida, T, Abe, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500841/
https://www.ncbi.nlm.nih.gov/pubmed/28192400
http://dx.doi.org/10.1038/onc.2016.519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500841/
https://www.ncbi.nlm.nih.gov/pubmed/28192400
http://dx.doi.org/10.1038/onc.2016.519

Ejemplares similares